Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of the American College of Emergency Physicians Open
|
March 24, 2025
Knee Pain After Jumping
Benjamin Stieren, Joseph Saad, Cindy C Bitter
Neuropsychology
|
July 3, 2025
Monolinguals outperform bilinguals in language but not executive function in aging and cognitive impairment
Stefanie Gard, Joseph Saad, Christine L Sheppard, et al.
Frontiers in Pharmacology
|
March 7, 2019
Making Sense of the Epigenome Using Data Integration Approaches
Emma Cazaly, Joseph Saad, Wenyu Wang, et al.
Biomarker Research
|
June 18, 2026
NAMPT haploinsufficiency is a therapeutic vulnerability to NAMPT inhibition in -7/-7q MDS
Nemo Ikonen, Tanja Ruokoranta, Salla Hyyppä, et al.
Blood Advances
|
January 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia
Samuli Eldfors, Joseph Saad, Nemo Ikonen, et al.
Nucleic Acids Research
|
May 9, 2019
DrugComb: an integrative cancer drug combination data portal
Bulat Zagidullin, Jehad Aldahdooh, Shuyu Zheng, et al.
Hemasphere
|
January 14, 2026
Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy
Ida Vänttinen, Joseph Saad, Tanja Ruokoranta, et al.
Molecular Oncology
|
September 21, 2025
Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, et al.
The Journal of Experimental Medicine
|
September 2, 2022
Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine
Ujunwa Cynthia Okoye-Okafor, Komal K Javarappa, Dimitrios Tsallos, et al.
Blood
|
October 2, 2024
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial
Sari Kytölä, Ida Vänttinen, Tanja Ruokoranta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of the American College of Emergency Physicians Open
|
March 24, 2025
Knee Pain After Jumping
Benjamin Stieren, Joseph Saad, Cindy C Bitter
Neuropsychology
|
July 3, 2025
Monolinguals outperform bilinguals in language but not executive function in aging and cognitive impairment
Stefanie Gard, Joseph Saad, Christine L Sheppard, et al.
Frontiers in Pharmacology
|
March 7, 2019
Making Sense of the Epigenome Using Data Integration Approaches
Emma Cazaly, Joseph Saad, Wenyu Wang, et al.
Biomarker Research
|
June 18, 2026
NAMPT haploinsufficiency is a therapeutic vulnerability to NAMPT inhibition in -7/-7q MDS
Nemo Ikonen, Tanja Ruokoranta, Salla Hyyppä, et al.
Blood Advances
|
January 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia
Samuli Eldfors, Joseph Saad, Nemo Ikonen, et al.
Nucleic Acids Research
|
May 9, 2019
DrugComb: an integrative cancer drug combination data portal
Bulat Zagidullin, Jehad Aldahdooh, Shuyu Zheng, et al.
Hemasphere
|
January 14, 2026
Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy
Ida Vänttinen, Joseph Saad, Tanja Ruokoranta, et al.
Molecular Oncology
|
September 21, 2025
Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, et al.
The Journal of Experimental Medicine
|
September 2, 2022
Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine
Ujunwa Cynthia Okoye-Okafor, Komal K Javarappa, Dimitrios Tsallos, et al.
Blood
|
October 2, 2024
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial
Sari Kytölä, Ida Vänttinen, Tanja Ruokoranta, et al.
Page
of 2